Biocon Ltd.

NSE: BIOCON  SECTOR: Pharmaceuticals & Drugs

429.35
+3.4 (0.8%)

Price Summary

Today's High

₹ 434.85

Today's Low

₹ 423

52 Week High

₹ 477.9

52 Week Low

₹ 235.8

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

51522 Cr.

Enterprise Value

51148.1 Cr.

No. of Shares

120 Cr.

P/E

130.73

P/B

6.63

Face Value

₹ 5

Div. Yield

0%

Book Value (TTM)

₹  64.7267

CASH

375.3 Cr.

DEBT

1.4 Cr.

Promoter Holding

60.67%

EPS (TTM)

₹  3.2842

Sales Growth

-24.5083468703556%

ROE

6.07802591673559 %

ROCE

7.62172551736316 %

Profit Growth

20.1858804138815 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year-24.51%
3 Year-5.5%
5 Year-0.52%

Profit Growth (in Cr.)

1 Year-10.51%
3 Year-5.31%
5 Year4.07%

ROE%

1 Year6.08%
3 Year5.62%
5 Year6.76%

ROCE %

1 Year7.62%
3 Year6.68%
5 Year8.15%

Debt/Equity

0.000187846341692496

Price to Cash Flow

133.1

Interest Cover Ratio

467.583333333333

CFO/PAT (5 Yr. Avg.)

0.702594594475326

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2020 60.67 0
Dec 2019 60.67 0
Sep 2019 60.67 0
Jun 2019 60.67 0
Mar 2019 60.67 0
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 70 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 467.583333333333.
  • Company has a healthy liquidity position with current ratio of 2.86222527472527.
  • The company has a high promoter holding of 60.67%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.56690989760607.

 Limitations

  • The company has shown a poor profit growth of -5.30931489985296% for the Past 3 years.
  • The company has shown a poor revenue growth of -5.49641059405959% for the Past 3 years.
  • Company has a poor ROE of 5.6220189421201% over the past 3 years.
  • Company has contingent liabilities of 2046.8 Cr.
  • The company is trading at a high PE of 130.73.
  • The company is trading at a high EV/EBITDA of 98.7796.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Net Sales 523.9 501.3 482.4 520.7 560
Total Expenditure 434 424.3 439 404 472.1
Operating Profit 89.9 77 43.4 116.7 87.9
Other Income 60.3 51.2 67.2 36 38.4
Interest 0.4 0.1 0.2 0.1 0.1
Depreciation 24.1 25.3 24.6 25.7 26.4
Exceptional Items 0 55 22.7 0 0
Profit Before Tax 125.7 157.8 108.5 126.9 99.8
Tax 25.7 37.1 14.9 42.1 4.8
Profit After Tax 100 120.7 93.6 84.8 95
Adjusted EPS (Rs) 0.08 0.1 0.08 0.07 0.08

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 2301.8 2587.9 2419.2 2893.3 2184.2
Total Expenditure 1880 1996.1 2101 2554.3 1889.4
Operating Profit 421.8 591.8 318.2 339 294.8
Other Income 173.1 98.8 124.7 109.3 204.6
Interest 1.9 3.8 1 2.6 1.2
Depreciation 139.7 150.6 136.1 92.3 98
Exceptional Items 106.1 0 0 198.7 159.7
Profit Before Tax 559.4 536.2 305.8 552.1 559.9
Tax 190.8 16.9 67.3 59.4 119
Net Profit 368.6 519.3 238.5 492.7 440.9
Adjusted EPS (Rs.) 3.07 4.33 1.99 4.11 3.67

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 100 100 300 300 600
Total Reserves 5896.6 6441.1 6438.6 6815.4 6937.3
Borrowings 136.5 132.4 67.2 1.4 0.7
Other N/C liabilities 102.4 -15.2 -12.7 -71.6 -134.7
Current liabilities 862.6 705.2 831.6 993.3 728
Total Liabilities 7098.1 7363.5 7624.7 8038.5 8131.3
Assets
Net Block 893.8 894.1 858.8 1059.2 720.7
Capital WIP 172.3 240.8 318.5 254.5 151.9
Investments 3254.5 3407.4 3789 4021.6 4886.5
Loans & Advances 371.7 402.6 558.7 180.7 280.9
Other N/C Assets 34.7 40.1 42 11.1 7.6
Current Assets 2371.1 2378.5 2057.7 2511.4 2083.7
Total Assets 7098.1 7363.5 7624.7 8038.5 8131.3
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 559.4 536.2 305.8 552.1 559.9
Adjustment -87.9 110.8 64.9 -111.8 -68.1
Working Capital Changes -57.8 -340.5 72.2 -193.9 -14
Tax Paid -205.2 -120.7 -87.7 -136.9 -90.7
Operating Cash Flow 208.5 185.8 355.2 109.5 387.1
Investing Cash Flow -321.1 110.4 -555.5 310.9 -212.9
Financing Cash Flow 73 -238.3 -54.6 -208.2 -128.9
Net Cash Flow -39.6 57.9 -254.9 212.2 45.3

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Biocon Stock Price Analysis and Quick Research Report. Is Biocon an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Biocon and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 387.1 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Biocon has a Debt to Equity ratio of 0.000187846341692496 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Biocon , the EPS growth was -55.2567485285163 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Biocon has OPM of 13.4969325153374 % which is a bad sign for profitability.
     
  • ROE: Biocon have a poor ROE of 6.07802591673559 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Biocon

X